Table 2.

Univariate analysis for overall survival of glioma patients

Variables	Patients (n=65)	Overall survival time (months)		P-value
		Mean ± SD	Median
Gender				0.961
Female	41	42.51±3.32	45.00
Male	24	38.60±5.14	34.00
Age (years)				0.521
≤50	35	40.47±4.21	46.00
>50	30	41.69±3.76	42.00
Tumor size				0.048*
≤5 cm	32	42.27±3.74	44.00
>5 cm	33	35.08±4.04	34.00
WHO grade				0.001*
II	31	52.36±3.28	54.0
III–IV	34	30.59±3.69	22.0
Karnofsky score				0.847
≤90	40	40.03±3.70	44.0
>90	25	42.92±4.48	42.0
LOXL2 expression				0.003*
Low	42	47.75±3.18	52.0
High	23	29.11±4.71	31.0

Note:

^*Statistically significant by log-rank test.

Abbreviations: LOXL2, lysyl oxidase-like 2; WHO, World Health Organization.